Axsome Therapeutics, Inc. (AXSM)
234.55
+0.35
(+0.15%)
USD |
NASDAQ |
May 27, 16:00
234.55
0.00 (0.00%)
After-Hours: 16:33
Axsome Therapeutics Cash from Investing (Quarterly) : -0.121M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -3.916B |
| Merck & Co., Inc. | -10.21B |
| Esperion Therapeutics, Inc. | -0.189M |
| Ocular Therapeutix, Inc. | -4.662M |
| Bristol Myers Squibb Co. | -131.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.70M |
| Cash from Financing (Quarterly) | 2.994M |
| Free Cash Flow | -70.99M |
| Free Cash Flow Per Share (Quarterly) | -0.4067 |
| Free Cash Flow to Equity (Quarterly) | -22.61M |
| Free Cash Flow to Firm (Quarterly) | -17.73M |
| Free Cash Flow Yield | -0.60% |